Error: Could not add to watchlist. X
+ Watchlist

Global Immune Technologies Inc

GIMU:US
OTC US
0.00
USD
0.00
25.00%
As of 8:10 PM EDT 6/20/2016
Open
0.00
Day Range
0.00 - 0.00
Volume
170
Previous Close
0.00
52Wk Range
0.00 - 0.00
Open
0.00
Day Range
0.00 - 0.00
Volume
170
Previous Close
0.00
52Wk Range
0.00 - 0.00
YTD Return
66.67%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
0.00
Market Cap (k USD)
78.675
Shares Outstanding (m)
157.350
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Industrials
Industry
Electrical Equipment
Sub-Industry
Comml & Res Bldg Equip & Sys

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Global Immune Technologies, Inc. owns all rights and interests to the drug Trioxolane. The drug acts to reinforce the natural immune system and regulate the production of serotonin, prostaglandin and inflammatory interleukins.
Address
2809 Great Northern Loop
Suite 100
Missoula, MT 59808-1749
United States
Phone
1-406-322-3844
Show More